ALSO NOTED: Novartis cuts 1,260 jobs; Nektar hammered on Exubera decision; and much more...

> Slammed by weak sales last quarter, Novartis announced that it will lay off 1,260 in the U.S. and rearrange its management. Report

> Pfizer wasn't the only casualty in today's announcement that Exubera was being dropped after disappointing sales. Nektar, which garnered a 15 percent sales royalty on the drug, say its shares plunge on the news. Nektar gets the rights back. Report

> Isis Pharmaceuticals has added a new diabetes drug targeting the sodium dependent glucose transporter type 2 (SGLT2) to its development pipeline. Release

> An Indian state is planning a new biotech research center. Report

> Microban international is expanding with 45 new jobs. Report

> In yet another blow to the embattled diabetes drug Avandia, the Department of Veterans Affairs is severely restricting its use. Until now, the VA accounted for about 8 percent of Avandia sales. Report

> Amgen is playing hardball to protect its anemia drugs as Roche prepares to launch a competing product, Mircera, next month. Report

> In a sort of good news/bad news move, the FDA is allowing Merck to expand marketing of the diabetes drug Januvia--but it's also expanding the warnings on Januvia's label. Report

> Acclaimed Australian stem cell scientist Alan Trounson, who was recently appointed to head up California's $3 billion stem cell institute, has been questioned in an investigation related to "anomalies" in interim results presented for an aborted $1 million lung regeneration research project. Report

And Finally... One new study out of the UK says that swearing in the office is a great way to build teams and blow off steam. Report

Suggested Articles

Pfizer's eczema hopeful has been building its case to challenge Sanofi and Regeneron's Dupixent, but safety issues could stand in its way.

Cedrik Britten, M.D., becomes the biotech’s new chief medical officer to help run its adoptive cell therapy and TCR bispecifics platform.

Broad Institute researchers showed that base-editing the Tmc1 gene preserved hair cells that helped transmit sound in the ears of mice.